Suppr超能文献

纳曲酮和阿坎酸治疗酒精依赖的疗效与安全性:一项系统评价

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

作者信息

Bouza Carmen, Angeles Magro, Muñoz Ana, Amate José María

机构信息

Agency for Health Technology Assessment, Madrid, Spain.

出版信息

Addiction. 2004 Jul;99(7):811-28. doi: 10.1111/j.1360-0443.2004.00763.x.

Abstract

AIMS

To ascertain the efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence.

METHODS

Systematic review of the literature (1990-2002) and meta-analysis of full published randomized and controlled clinical trials assessing acamprosate or naltrexone therapy in alcohol dependence. Estimates of effect were calculated according to the fixed-effects model.

MEASUREMENTS

Relapse and abstinence rates, cumulative abstinence duration and treatment compliance were considered as primary outcomes. Findings Thirty-three studies met the inclusion criteria. Acamprosate was associated with a significant improvement in abstinence rate [odds ratio (OR): 1.88 (1.57, 2.25), P < 0.001] and days of cumulative abstinence [WMD: 26.55 (17.56, 36.54]. Short-term administration of naltrexone reduced the relapse rate significantly [OR: 0.62 (0.52, 0.75), P < 0.001], but was not associated with a significant modification in the abstinence rate [OR: 1.26 (0.97,1.64), P = 0.08]. There were insufficient data to ascertain naltrexone's efficacy over more prolonged periods. Acamprosate had a good safety pattern and was associated with a significant improvement in treatment compliance [OR: 1.29 (1.13,1.47), P < 0.001]. Naltrexone's side effects were more numerous, yet the drug was nevertheless tolerated acceptably without being associated with a lower adherence to treatment (OR: 0.94 (0.80, 1.1), P = 0.5). However, overall compliance was relatively low with both medications.

CONCLUSIONS

Both acamprosate and naltrexone are effective as adjuvant therapies for alcohol dependence in adults. Acamprosate appears to be especially useful in a therapeutic approach targeted at achieving abstinence, whereas naltrexone seems more indicated in programmes geared to controlled consumption. Both drugs are safe and acceptably tolerated but issues of compliance need to be addressed adequately to assure their usefulness in clinical practice.

摘要

目的

确定纳曲酮和阿坎酸在治疗酒精依赖方面的疗效和安全性。

方法

对1990年至2002年的文献进行系统回顾,并对已发表的评估阿坎酸或纳曲酮治疗酒精依赖的随机对照临床试验进行荟萃分析。根据固定效应模型计算效应估计值。

测量指标

复发率和戒断率、累积戒断持续时间和治疗依从性被视为主要结果。结果33项研究符合纳入标准。阿坎酸与戒断率显著改善相关[优势比(OR):1.88(1.57,2.25),P<0.001]和累积戒断天数相关[加权均数差(WMD):26.55(17.56,36.54)]。短期服用纳曲酮可显著降低复发率[OR:0.62(0.52,0.75),P<0.001],但与戒断率的显著改变无关[OR:1.26(0.97,1.64),P=0.08]。没有足够的数据来确定纳曲酮在更长时间内的疗效。阿坎酸具有良好的安全性,与治疗依从性的显著改善相关[OR:1.29(1.13,1.47),P<0.001]。纳曲酮的副作用更多,但该药物仍能被接受,且与较低的治疗依从性无关(OR:0.94(0.80,1.1),P=0.5)。然而,两种药物的总体依从性都相对较低。

结论

阿坎酸和纳曲酮均作为成人酒精依赖的辅助治疗有效。阿坎酸在旨在实现戒酒的治疗方法中似乎特别有用,而纳曲酮在旨在控制饮酒量的方案中似乎更适用。两种药物都安全且耐受性良好,但需要充分解决依从性问题以确保其在临床实践中的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验